Nader said only approved ccr5 inhibitor on the market is maraviroc aka selzentry - had $200mil 2013 sales treating 20-30k people.
That works out to roughly $8k a patient. US market alone for those with HIV ccr5 tropism almost 400k -
$8k x even a fraction of the market = many billions$$$
maraviroc/selzentry has struggled to gain market share because it blocks the normal function of ccr5 (inflammation), has nasty side effects, and develops resistance
PRO 140 doesn't impede the normal ccr5 function, has little/no toxicity and stops maraviroc viruses
Keep spreading the good word - THIS WILL LITERALLY IMPROVE THE LIVES OF MILLIONS!